major-depressive-disorder

Documents about major-depressive-disorder

• Exploring the Development of Self-Efficacy to Impact Discharge Preparedness in Major Depressive Disorder After Engaging in an Occupational Therapy Interactive Group Model Intervention#632368WIReDSpace
• Feasibility Study to Test Clinical Efficacy of Low Energy AC Magnetic Field to Treat Major Depression#830612ClinicalTrials.gov
• Lumateperone for Late-Life Depression#883365ClinicalTrials.gov
• Remotely Programmed Deep Brain Stimulation of the Bilateral Habenula for Treatment- Resistant Major Depression: An Open Label Pilot Trial#890327ClinicalTrials.gov
• Biomarkers of Social Sensitivity in Major Depression#898831ClinicalTrials.gov
• Antidepressant Treatment of Mexican-Americans: UCLA Pharmacogenetics and Pharmacogenomics Research Group#917727ClinicalTrials.gov
• Partnership in Medication Management (PIMM) in Patients With Mood Disorders#894906ClinicalTrials.gov
• Transdiagnostic Markers of Cognitive Symptoms in Disorders Affective.#993601ClinicalTrials.gov
• Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies#7272OpenAlex
• Anticipatory pleasure as a key hedonic component in classifying major depressive disorder: multidimensional behavioral evidence from majority vote algorithm.#159700NCBI PubMed Central
• Depression and hypothyroidism: A systematic review#355277RCAAP
• Predicting Dropout in Psychotherapy for Major Depressive Disorder: A Machine Learning Approach to Identifying At-Risk Patients.#455539NCBI PubMed Central
• IL-1α and CRP as key inflammatory mediators linking neuropathic pain, anxiety, and depression in major depressive disorder.#464961NCBI PubMed Central
• Neurocognitive Mechanisms of Preventive Cognitive Therapy as Relapse Prevention in Remitted Major Depressive Disorder: A Randomized Controlled Trial.#630758NCBI PubMed Central
• The role of sphingolipids in major depressive disorder and associated cognitive impairment: interactions with monoaminergic signaling, neuroinflammation, and neurogenesis.#785519NCBI PubMed Central
• Acamprosate Added to Escitalopram and Behavioral Treatment for Comorbid Depression and Alcoholism#802502ClinicalTrials.gov
• A Trial of Enhanced Versus Standard Measurement-Based Care Implementation for Depression#805831ClinicalTrials.gov
• Antidepressant Safety in Kids Study#811740ClinicalTrials.gov
• Resonant Frequency rTMS: A Novel Approach to Target Circuit Modulation in Major Depressive Disorder#830036ClinicalTrials.gov
• Glutamatergic Adaptation to Stress as a Mechanism for Anhedonia and Treatment Response With Ketamine#835470ClinicalTrials.gov
• Development of Attentional Biases for Affective Cues in Infants of Mothers With Depression#860690ClinicalTrials.gov
• No Time to Wait: Single Session Intervention#903126ClinicalTrials.gov
• Deep Brain Stimulation for Treatment Resistant Depression#908398ClinicalTrials.gov
• Psychophysiological Study of Pain Perception in Depressed Patients With Suicidal Risk#909218ClinicalTrials.gov
• Light Therapy for Depression During Pregnancy#911062ClinicalTrials.gov
• rTMS for Depressed Teens: A Sham-Controlled Trial, Part 2#994016ClinicalTrials.gov
• The Effect of Probiotic Supplementation on the Mental Status, Inflammation, and Intestinal Barrier in Major Depressive Disorder Patients Using Gluten-free or Gluten-containing Diet#876169ClinicalTrials.gov
• Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic#7329OpenAlex
• Hyperventilation Combined With Etomidate or Ketamine Anesthesia in ECT Treatment of Major Depression#802836ClinicalTrials.gov
• Serotonin Transporter Genetic Variation and Amygdala Responses to Antidepressant Medications in Major Depression#875061ClinicalTrials.gov
• Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations#811055ClinicalTrials.gov
• Genetic predispositions for anxiety disorders and major depressive disorder affect current dietary habits in older patients with lifestyle-related diseases.#13482NCBI PubMed Central
• Interindividual differences in digital phenotypes of major depressive disorder: A passive sensing study using smartphone and wearable sensor data.#123110NCBI PubMed Central
• Psychiatric safety of methylphenidate in adults with major depressive disorder: a 1-year retrospective cohort study of 6,422 patients.#185841NCBI PubMed Central
• Major depressive disorder is associated with reduced intrinsic connectivity between the bed nucleus of the stria terminalis and ventral striatum.#227679NCBI PubMed Central
• Data supporting: 'Anhedonia and its sub-component processes predict clinically significant symptoms of major depressive disorder (MDD) and loneliness in young people'#296131University of Reading Research Data Archive
• Effect of depression on personality#296451Zenodo (CERN)
• Advances in the Application of Brain–Computer Interface-Based Neurofeedback Training in the Rehabilitation of Patients with Major Depressive Disorder.#327207NCBI PubMed Central
• A Study Comparing the Efficacy and Safety of Duloxetine and Placebo for the Treatment of Depression in Elderly Patients#343730ClinicalTrials.gov
• A precision medicine trial of bupropion and sertraline for major depressive disorder using a biomarker-guided sequential multiple-assignment design.#354534NCBI PubMed Central
• Fatigue Symptoms Influence Effort-Based Decision-Making in Major Depressive Disorder#485132Europe PMC
• Optimized multichannel 4 mA vs conventional transcranial direct current stimulation for major depressive disorder: A randomized sham-controlled trial#642390Europe PMC
• Left Cerebellar-Right Frontal Uncoupling in Female First-Episode Major Depressive Disorder: Synaptic Evidence From [(18)F]UCB-H PET.#662589NCBI PubMed Central
• Genetic and epigenetic architecture of mass spectrometry-derived lipids in blood and their role in lifetime Major Depressive Disorder#684629Europe PMC
• Altered functional connectivity in fronto-limbic circuits, dysregulation of the hypothalamic-pituitary-adrenal axis (HPA), and serotonergic dysfunction in Major Depressive Disorder (MDD)#694701PhilArchive
• Ketamine in the Treatment of Suicidal Depression#803587ClinicalTrials.gov
• Elevated Plasma DISC1 Levels Are Associated With Motivational Deficits in Medication-Free Patients With Major Depressive Disorder: An Exploratory Study.#823448NCBI PubMed Central
• Selenium Supplementation for Improving Depression in Children and Adolescents: Efficacy and Mechanistic Study#828588ClinicalTrials.gov
• Low-Dose Naltrexone (LDN) for Depression Relapse and Recurrence#839148ClinicalTrials.gov
• Safety Study of Ziprasidone (Geodon) for the Depressive Mixed State#848287ClinicalTrials.gov